HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Krishne Gowda Selected Research

SGA 360

12/2017Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Krishne Gowda Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 01/2013
6Carcinogenesis
01/2022 - 08/2016
3Mouth Neoplasms (Oral Cancer)
01/2022 - 01/2017
2Breast Neoplasms (Breast Cancer)
11/2021 - 02/2015
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2018
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 10/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 08/2014
2Multiple Myeloma
01/2020 - 01/2017
2Squamous Cell Carcinoma of Head and Neck
01/2020 - 01/2019
2Leukemia
01/2020 - 10/2015
2Oral Leukoplakia
01/2019 - 12/2017
1Infections
01/2021
1Papilloma (Papillomatosis)
01/2021
1Papillomavirus Infections
01/2021
1Hyperplasia
01/2021
1Metabolic Diseases (Metabolic Disease)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Acne Vulgaris
06/2019
1Chloracne
06/2019
1Inflammation (Inflammations)
12/2017
1Gout
12/2017
1Edema (Dropsy)
12/2017
1Shock
12/2017
1Leukoplakia
08/2016
1Autoimmune Diseases (Autoimmune Disease)
06/2015
1Skin Diseases (Skin Disease)
05/2015
1Rheumatoid Arthritis
02/2014
1Disease Progression
02/2014
1Melanoma (Melanoma, Malignant)
01/2013
1Human Influenza (Influenza)
01/2012
1Prostatic Neoplasms (Prostate Cancer)
01/2007

Drug/Important Bio-Agent (IBA)

10dibenzo(a,l)pyreneIBA
01/2022 - 07/2015
6SmokeIBA
01/2022 - 01/2018
4DNA AdductsIBA
01/2022 - 12/2017
4Environmental Pollutants (Pollutants, Environmental)IBA
01/2021 - 10/2017
4CarcinogensIBA
01/2021 - 01/2017
4Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
06/2019 - 02/2014
3Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2022 - 07/2015
3EnzymesIBA
02/2020 - 01/2012
3LigandsIBA
06/2019 - 01/2007
3Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2014
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
24-oxo-5,7,10,13,16,19-docosahexaenoic acidIBA
11/2021 - 02/2015
2Docosahexaenoic AcidsIBA
11/2021 - 02/2015
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2012
2Oxidoreductases (Dehydrogenase)IBA
02/2020 - 01/2020
2AldehydesIBA
02/2020 - 01/2020
2Protein Isoforms (Isoforms)IBA
02/2020 - 01/2020
2Pharmaceutical PreparationsIBA
01/2020 - 01/2013
2Casein Kinase II (Casein Kinase 2)IBA
01/2020 - 10/2015
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2020 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
11/2018 - 10/2015
2Biological ProductsIBA
01/2018 - 10/2006
2marinopyrrole AIBA
08/2014 - 01/2013
1Benzo(a)pyreneIBA
01/2022
1Lipoxygenase (Lipoxygenase-1)IBA
11/2021
1Dinoprostone (PGE2)FDA Link
11/2021
1Antineoplastic Agents (Antineoplastics)IBA
11/2021
115-hydroxyprostaglandin dehydrogenaseIBA
11/2021
1Viral DNAIBA
01/2021
1Viral ProteinsIBA
01/2021
1silmitasertibIBA
01/2020
1Aldehyde DehydrogenaseIBA
01/2020
1Environmental CarcinogensIBA
01/2020
1CholesterolIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1IsatinIBA
01/2020
1LipidsIBA
06/2019
1Polychlorinated Dibenzodioxins (TCDD)IBA
06/2019
1N'-nitrosonornicotine (nitrosonornicotine)IBA
01/2019
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
11/2018
1dibenzo(a,l)pyrene diol epoxideIBA
01/2018
1PowdersIBA
01/2018
1Epoxy Compounds (Epoxides)IBA
01/2018
1Anthocyanins (Anthocyanin)IBA
12/2017
1trans-1,2-dihydro-1,2-naphthalenediolIBA
12/2017
1SGA 360IBA
12/2017
1LipopolysaccharidesIBA
12/2017
1Uric Acid (Urate)IBA
12/2017
1TubulinIBA
01/2017
1Indicators and Reagents (Reagents)IBA
08/2016
12',7'-dichlorodihydrofluorescein diacetateIBA
08/2016
1Therapeutic UsesIBA
10/2015
1navitoclaxIBA
05/2015
1venetoclaxIBA
05/2015
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
02/2015
1Phenobarbital (Luminal)FDA Link
02/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2014
1pyoluteorinIBA
01/2014
1Apoptosis Regulatory ProteinsIBA
01/2013
1ABT-737IBA
01/2013
1CaspasesIBA
01/2013
1Messenger RNA (mRNA)IBA
01/2012
1Exonucleases (3' 5' Exonuclease)IBA
01/2012
1Androgen Receptors (Androgen Receptor)IBA
01/2007
1Peptides (Polypeptides)IBA
01/2007
1Co-Repressor ProteinsIBA
01/2007

Therapy/Procedure

4Therapeutics
01/2020 - 01/2013
2Drug Therapy (Chemotherapy)
01/2020 - 05/2015
1Chemoprevention
01/2019